Your browser doesn't support javascript.
loading
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world study.
Nannini, M; Rizzo, A; Nigro, M C; Vincenzi, B; Mazzocca, A; Grignani, G; Merlini, A; D'Ambrosio, L; Tolomeo, F; Badalamenti, G; Incorvaia, L; Bonasera, A; Fumagalli, E; Miliziano, D; Ligorio, F; Brunello, A; Chiusole, B; Gasperoni, S; Novelli, M; Pantaleo, M A.
Affiliation
  • Nannini M; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Electronic address: margherita.nannini@aosp.bo.it.
  • Rizzo A; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Nigro MC; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Vincenzi B; Department of Oncology, University Campus Bio-Medico, Rome, Italy.
  • Mazzocca A; Department of Oncology, University Campus Bio-Medico, Rome, Italy.
  • Grignani G; Division of Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  • Merlini A; Division of Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  • D'Ambrosio L; Division of Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  • Tolomeo F; Division of Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  • Badalamenti G; Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
  • Incorvaia L; Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
  • Bonasera A; Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
  • Fumagalli E; Adult Mesenchymal Tumour and Rare Cancer Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Miliziano D; Adult Mesenchymal Tumour and Rare Cancer Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Ligorio F; Adult Mesenchymal Tumour and Rare Cancer Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Brunello A; Medical Oncology 1, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
  • Chiusole B; Medical Oncology 1, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
  • Gasperoni S; Translational Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy.
  • Novelli M; Department of Statistical Sciences, University of Bologna, Bologna, Italy.
  • Pantaleo MA; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
ESMO Open ; 6(4): 100222, 2021 08.
Article in En | MEDLINE | ID: mdl-34352702
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Stromal Tumors Type of study: Observational_studies Aspects: Patient_preference Limits: Humans Language: En Journal: ESMO Open Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Stromal Tumors Type of study: Observational_studies Aspects: Patient_preference Limits: Humans Language: En Journal: ESMO Open Year: 2021 Document type: Article